Extracellular Matrix-Guided Islet Cell Transplantation Results in Improved Glycemic Control in a NOD-SCID Mouse Model
Hormone and Metabolic Research · 01.12.2025 · 57 (12) · 697-704
DOI: 10.1055/a-2734-1983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.12.2025. Verfasst von Ruchama Korol und 14 weiteren Autor:innen. Beteiligte Einrichtung: Betalin Therapeutics Ltd., Jerusalem, Israel. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Extracellular Matrix, Diabetes Mellitus, Experimental, Glycemic Control. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Current insulin therapy fails to fully restore physiological glucose homeostasis in type 1 diabetes mellitus, with 75% of patients unable to achieve the desired management targets. While stem cell-derived islets offer promising therapy, they require an enhanced extracellular matrix support for optimal transplantation outcomes. To address this challenge, we developed biofunctional endocrine micro-pancreata using decellularized porcine lung scaffolds seeded with embryonic stem cell-derived islets. In vivo efficacy was evaluated following subcutaneous or intraperitoneal transplantation into NOD-SCID mice, followed by streptozotocin induction of diabetes, with the comprehensive assessment of human insulin secretion, glucose homeostasis, and graft integration over 3 months. Our results demonstrated that endocrine micro-pancreata exhibited 1.4-fold-increased glucose-stimulated insulin secretion in vitro compared to non-responsive free islets. In vivo, endocrine micro-pancreas recipients maintained significantly lower glucose levels than controls throughout the experiment. Subcutaneous endocrine micro-pancreata showed superior performance, with 46% improved glucose tolerance versus 31% improvement for intraperitoneal delivery. Extensive CD31-positive neovascularization as well as insulin staining confirmed successful graft integration and sustained insulin production. Endocrine micro-pancreata provide a scalable platform for diabetes cell therapy, demonstrating sustained insulin secretion and improved glycemic control. The preserved extracellular matrix microenvironment supports islet function and vascularization, offering significant potential for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Betalin Therapeutics Ltd., Jerusalem, Israel.
- Kadimastem Ltd., Jerusalem, Israel.
- Life Sciences, Tritel Patents, Ltd, Bet Shemesh, Israel.
- Department of Internal Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
- Paul Langerhans Institute Dresden of Helmholtz Centre Munich, University Hospital Carl Gustav Carus, Dresden, Germany.
- Center for Regenerative Therapies, Technische Universität Dresden, Dresden, Germany.
Zitieren
APA
Korol, R., Even-Ram, S., Molakandov, K., Puchinsky, D., Hemed, M., Mizrahi, N., Toledo, I., Lazar, D., Chebath, J., Tritel, M., Ofir, R., Ludwig, B., Revel, M., Shapiro, A. M. J., & Bornstein, S. R. (2025). Extracellular Matrix-Guided Islet Cell Transplantation Results in Improved Glycemic Control in a NOD-SCID Mouse Model. Hormone and Metabolic Research, 57(12), 697-704. https://doi.org/10.1055/a-2734-1983
Vancouver
Korol R, Even-Ram S, Molakandov K, Puchinsky D, Hemed M, Mizrahi N, et al. Extracellular Matrix-Guided Islet Cell Transplantation Results in Improved Glycemic Control in a NOD-SCID Mouse Model. Hormone and Metabolic Research. 2025;57(12):697-704. doi:10.1055/a-2734-1983
BibTeX
@article{Korol2025,
author = {Korol, Ruchama and Even-Ram, Sharona and Molakandov, Kfir and Puchinsky, Dmitry and Hemed, Maayan and Mizrahi, Noam and Toledo, Itzik and Lazar, Daniel and Chebath, Judith and Tritel, Moshe and Ofir, Racheli and Ludwig, Barbara and Revel, Michel and Shapiro, A M James and Bornstein, Stefan R},
title = {Extracellular Matrix-Guided Islet Cell Transplantation Results in Improved Glycemic Control in a NOD-SCID Mouse Model},
journal = {Hormone and Metabolic Research},
year = {2025},
volume = {57},
number = {12},
pages = {697--704},
doi = {10.1055/a-2734-1983}
}
EUVIMED